Sequenom (SQNM) Completes 14.95M Offering; Underwriters Exercise Full Overallotment

Sequenom, Inc. (Nasdaq: SQNM) today announced the completion of an underwritten public offering of 14,950,000 shares of its common stock, including 1,950,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters. All of the shares were offered by Sequenom at a price to the public of $4.15 per share. The gross proceeds to Sequenom from this offering were approximately $62.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Sequenom. Sequenom anticipates using the net proceeds from the offering for general corporate purposes, including research and development expenses, capital expenditures, working capital and general administrative expenses.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
• GE Vernova wins stage 3 contract for Queensland battery project
• Robo.ai names Hao Wang of Changer.ae to its board of directors